TP53 and cancer: Cells lacking gankyrin are more prone to erastin-induced ferroptosis, associated with increased p53 protein levels; gankyrin overexpression favors the MDM2-dependent ubiquitination of p53 with consequent upregulation of SLC7A11 and GPX4, thus facilitating cancer cell survival and impairing ferroptosis [193].